Markets /CERU Cerulean Pharma Inc. CERU Full chart Compare Add to watchlist Set alert Price alert · CERU Alert when the price is Price abovePrice below Price level Set alert All alert types No live quote for CERU yet. Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2025FY 2024 Other Income → Expenses: $153.06MExpenses → Selling, General & Admin: $8.76BExpenses → Research & Development: $5.52BGross Profit → Expenses: $734.39MRevenue → Gross Profit: $734.39MRevenue → Cost of Revenue: $295.80MNet Loss → Expenses: $13.40BOther Income$153.06MGross Profit$734.39MNet Loss$13.40BCost of Revenue$295.80MExpenses$14.29BSelling, General & Admin$8.76BResearch & Development$5.52BRevenue$1.03B No annual statement lines CERU has no annual lines for this statement.